Strategic Positioning MemoryMD operates within the medical device sector with strong AI and deep learning background, now under Brain Scientific, signaling potential for cross-sell of FDA-cleared neurodiagnostic devices and AI-powered brain analysis solutions to neurohospital networks and pediatric EEG markets.

Distribution Expansion Recent distribution partnerships and expansion efforts in India and the US suggest a growing channel strategy; leverage these partnerships to accelerate hospital and clinic adoption of NeuroCap and NeuroEEG products in underserved regional markets.

Public Market Access The company’s NASDAQ listing and ongoing investor relations activity indicate increasing visibility and credibility; target budget-conscious hospital systems and purchasing groups seeking investable, scalable neurodiagnostic platforms.

Product Roadmap Frequent device updates and FDA-cleared offerings create opportunities for refresh cycles in hospitals; propose bundled sales with service, training, and remote monitoring to drive repeat purchases and long-term contracts.

Industry Partnerships Active collaborations with distributors and medical suppliers across regions point to a ready-made network; prioritize strategic outreach to key distributors, B2B clinics, and pediatric EEG centers to accelerate volume-based deals.